Airlangga University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Surabaya Indonesia (1954)

Organization Overview

First Clinical Trial
2011
NCT01433562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Airlangga University | Child Health Dept. Dr. Soetomo Hospital/School of Medicine, Airlangga Univ. | Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Airlangga, Dr. Soetomo Hospital, Surabaya, Indonesia. | Dr. Soetomo Hospital | Neurology Department Dr. Soetomo Hospital | RS DR Soetomo Surabaya | Surabaya Diabetes and Nutrition Center, Dr. Soetomo Hospital | Surgery-Oncology Division, Department of Surgery, Faculty of Medicine, University of Airlangga / Dr. Soetomo Hospital | Universitas Airlangga | University of Airlangga

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Cerebral Infarction (Phase 3)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Eclampsia (Phase 2)

Infarction (Phase 3)

Insulin Resistance (Phase 3)

Ischemia (Phase 3)

Measles (Phase 4)

Polycystic Ovary Syndrome (Phase 3)

Pre-Eclampsia (Phase 2)

Rubella (Phase 4)

Stroke (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 12